Mencacci Niccolo E, Jinnah H A
Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Departments of Neurology, Human Genetics and Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Tremor Other Hyperkinet Mov (N Y). 2019 Aug 28;9. doi: 10.7916/tohm.v0.710. eCollection 2019.
Dystonias are a clinically and etiologically diverse group of disorders. Numerous genes have now been associated with different dystonia syndromes, and multiple strategies have been proposed for how these genes should be lumped and split into meaningful categories. The traditional approach has been based on the Human Genome Organization's plan for naming genetic loci for all disorders. For dystonia this involves a DYT prefix followed by a number (e.g., DYT1, DYT2, DYT3, etc.). A more recently proposed approach involves assigning multiple prefixes according to the main elements of the phenotype (e.g., DYT, PARK, CHOR, TREM, etc.) followed by the name of the responsible gene. This article describes these nomenclature systems and summarizes some of their limitations. We focus on dystonia as an example, although the concepts may be applied to all movement disorders.
肌张力障碍是一组临床和病因各异的疾病。目前,许多基因已与不同的肌张力障碍综合征相关联,并且针对如何将这些基因归并和划分为有意义的类别提出了多种策略。传统方法基于人类基因组组织为所有疾病命名基因座的计划。对于肌张力障碍,这涉及一个DYT前缀,后面跟着一个数字(例如,DYT1、DYT2、DYT3等)。最近提出的一种方法是根据表型的主要元素分配多个前缀(例如,DYT、PARK、CHOR、TREM等),后面跟着致病基因的名称。本文描述了这些命名系统并总结了它们的一些局限性。我们以肌张力障碍为例进行重点阐述,尽管这些概念可能适用于所有运动障碍。